SCHEMBL1243435

SCHEMBL1243435

CCC(NC(=O)c1cn(C2CCNC2)c2cc(NC3CCCCC3)c(F)cc2c1=O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
GAA P10253 2/20 0.52
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 5/20 0.40
LMNA P02545 3/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP1A2 P05177 1/20 0.40
TOP2A P11388 1/20 0.40
CYP2C9 P11712 1/20 0.40
TOP2B Q02880 1/20 0.40
MAPT P10636 1/20 0.38
FOXO1 Q12778 1/20 0.38
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
TP53 P04637 1/20 0.34
CASP3 P42574 1/20 0.34
CASP9 P55211 1/20 0.34
BAX Q07812 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242841 0.91 MEN1 (0.58) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1242761 0.86 MEN1 (0.52) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL4100133 0.85 MEN1 (0.53) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1242810 0.84 MEN1 (0.51) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL27656201 0.83 MEN1 (0.54) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1241043 0.83 MEN1 (0.54) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243323 0.83 MEN1 (0.75) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243443 0.83 MEN1 (0.49) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1242793 0.82 MEN1 (0.52) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL27656155 0.82 MEN1 (0.53) MEN1KMT2AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed